Wells Fargo’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Buy |
|
|||||
|
2025
Q1 | $1.93M | Buy |
|
|||||
|
2024
Q4 | $1.5M | Buy |
|
|||||
|
2024
Q3 | $1.32M | Sell |
|
|||||
|
2024
Q2 | $1.05M | Buy |
|
|||||
|
2024
Q1 | $862K | Buy |
|
|||||
|
2023
Q4 | $370K | Sell |
|
|||||
|
2023
Q3 | $1.28M | Buy |
|
|||||
|
2023
Q2 | $1.96M | Buy |
|
|||||
|
2023
Q1 | $781K | Buy |
|
|||||
|
2022
Q4 | $404 | Sell |
|
|||||
|
2022
Q3 | $19K | Sell |
|
|||||
|
2022
Q2 | $44K | Sell |
|
|||||
|
2022
Q1 | $616K | Sell |
|
|||||
|
2021
Q4 | $1.38M | Sell |
|
|||||
|
2021
Q3 | $1.04M | Buy |
|
|||||
|
2021
Q2 | $1.35M | Sell |
|
|||||
|
2021
Q1 | $995K | Sell |
|
|||||
|
2020
Q4 | $1.48M | Buy |
|
|||||
|
2020
Q3 | $514K | Buy |
|
|||||
|
2020
Q2 | $265K | Sell |
|
|||||
|
2020
Q1 | $343K | Buy |
|
|||||
|
2019
Q4 | $237K | Buy |
|
|||||
|
2019
Q3 | $312K | Buy |
|
|||||
|
2019
Q2 | $248K | Buy |
|
|||||
|
2019
Q1 | $205K | Sell |
|
|||||
|
2018
Q4 | $123K | Buy |
|
|||||
|
2018
Q3 | $130K | Sell |
|
|||||
|
2018
Q2 | $89K | Buy |
|
|||||
|
2018
Q1 | $73K | Buy |
|
|||||
|
2017
Q4 | $115K | Sell |
|
|||||
|
2017
Q3 | $169K | Buy |
|
|||||
|
2017
Q2 | $67K | Buy |
|
|||||
|
2017
Q1 | $67K | Hold |
|
|||||
|
2016
Q4 | $115K | Buy |
|